When combined with intravenous agalsidase alfa or beta, which are recombinant versions of the enzyme α-GalA,<unk>  increases tissue concentrations of functional α-GalA compared to agalsidase given alone up to fivefold.Migalastat is not intended to be combined with agalsidase.<unk>  does not inhibit or induce cytochrome P450 liver enzymes or transporter proteins and is therefore expected to have a low potential for interactions with other drugs.
Migalastat
Cobicistat
Lazaretto
Miglustat
Truenat
Epiestriol
Lifitegrast
Ketotifen